Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ AGC Biologics S.p.A.
AGC Biologics S.p.A.
Industry · 19 registered clinical trials.
Status
Trial
Phase
Started
Terminated
Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
Acute Myeloid Leukemia, Multiple Myeloma
Phase 1 / Phase 2
2019-08-27
Completed
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
Ovarian Cancer
Phase 2
2013-03-01
Completed
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
Ovarian Cancer
Phase 2
2011-06-01
Completed
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM
Advanced Malignant Pleural Mesothelioma
Phase 2
2011-03-01
Completed
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
Metastatic Adult Soft Tissue Sarcoma
Phase 2
2010-10-01
Completed
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrex
Malignant Pleural Mesothelioma
Phase 3
2010-04-12
Terminated
Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute
Acute Leukemia (Category)
Phase 3
2010-04-12
Completed
NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
2009-07-01
Completed
Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour
Solid Tumors
Phase 1
2009-04-01
Completed
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cance
Ovarian Cancer Metastatic Recurrent
Phase 2
2008-11-01
Completed
NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Col
Colon Cancer
Phase 2
2007-12-01
Completed
Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor
Solid Tumors
Phase 1
2007-07-01
Completed
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesotheliom
Malignant Pleural Mesothelioma
Phase 2
2007-05-01
Completed
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma
Small Cell Lung Cancer
Phase 2
2007-02-14
Completed
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC
Hepatocellular Carcinoma
Phase 2
2006-12-01
Completed
Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)
Colorectal Cancer (CRC)
Phase 2
2006-12-01
Completed
Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
Cancer
Phase 1
2006-02-28
Completed
A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
2005-03-01
Completed
Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignan
Hematological Malignancies
Phase 1 / Phase 2
2002-07-01